Renal health and the environment: heavy metal nephrotoxicity Nefrologa Everyone is talking about this FDA peptide update But almost no one is explaining it correctly. So let's break it down In 2023, many peptides were placed into Category 2 Renal Toxicity From Pemetrexed and Pembrolizumab in the Era of Combination Therapy in Patients With Metastatic Nonsquamous Cell NSCLC Journal of Thoracic Oncology Kidney Hypoxia, Attributable to Increased Oxygen Consumption, Induces Nephropathy Independently of Hyperglycemia and Oxidative Stress Hypertension